The drug volanesorsen (Waylivra), which is a 2- O -methoxyl-modified single-stranded antisense oligonucleotide (ASO) to the mRNA encoding apoC-III, has been found to reduce triglyceride levels in patients with classic familial chylomicronemia syndrome (FCS) on the order of 50%80%
Weekly tirzepitide shots immediately brought significant relief of pain, insomnia, and glycemic lability, but her symptoms reliably relapsed shortly before the next dosing
Vyleesi (bremelanotide) was FDA-approved in June 2019 for HSDD in premenopausal women based on Phase 3 clinical trial data
A 2012 study by Arakawa and colleagues of thyroid patients with Hashimotos and Graves, found that polymorphisms that is, gene variations that may lead to the abnormal expressions were as common in autoimmune thyroid disease as they were in the normal population
ValuePenguin health insurance expert Talon Abernathy says those high costs are consequential for everyone